• Blok narracyjny
• XML
• JSON
• TTL

: ActiveSubstanceCodeCodeSystem - JSON Representation

Active as of 2024-09-17

Raw json | Download

{
  "resourceType" : "CodeSystem",
  "id" : "PLActiveSubstanceCodeCodeSystem",
  "meta" : {
    "profile" : [
      🔗 "https://ezdrowie.gov.pl/fhir/StructureDefinition/PLSMPLAdminCodeSystem"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem PLActiveSubstanceCodeCodeSystem</b></p><a name=\"PLActiveSubstanceCodeCodeSystem\"> </a><a name=\"hcPLActiveSubstanceCodeCodeSystem\"> </a><a name=\"PLActiveSubstanceCodeCodeSystem-pl-PL\"> </a><p>This case-sensitive code system <code>https://ezdrowie.gov.pl/fhir/CodeSystem/PLActiveSubstanceCodeCodeSystem</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">larotrektynib<a name=\"PLActiveSubstanceCodeCodeSystem-larotrektynib\"> </a></td><td>Larotrektynib</td></tr><tr><td style=\"white-space:nowrap\">cetuksymab<a name=\"PLActiveSubstanceCodeCodeSystem-cetuksymab\"> </a></td><td>Cetuksymab</td></tr><tr><td style=\"white-space:nowrap\">panitumumab<a name=\"PLActiveSubstanceCodeCodeSystem-panitumumab\"> </a></td><td>Panitumumab</td></tr><tr><td style=\"white-space:nowrap\">adalimumab<a name=\"PLActiveSubstanceCodeCodeSystem-adalimumab\"> </a></td><td>Adalimumab (dostępny w terapii pacjentów od 4 r.ż.)</td></tr><tr><td style=\"white-space:nowrap\">etanercept<a name=\"PLActiveSubstanceCodeCodeSystem-etanercept\"> </a></td><td>Etanercept (dostępny w terapii pacjentów od 6 r.ż.)</td></tr><tr><td style=\"white-space:nowrap\">infliksymab<a name=\"PLActiveSubstanceCodeCodeSystem-infliksymab\"> </a></td><td>Infliksymab</td></tr><tr><td style=\"white-space:nowrap\">iksekizumab<a name=\"PLActiveSubstanceCodeCodeSystem-iksekizumab\"> </a></td><td>Iksekizumab (dostępny w terapii pacjentów od 6 r.ż.)</td></tr><tr><td style=\"white-space:nowrap\">sekukinumab<a name=\"PLActiveSubstanceCodeCodeSystem-sekukinumab\"> </a></td><td>Sekukinumab (dostępny w terapii pacjentów od 6 r.ż.)</td></tr><tr><td style=\"white-space:nowrap\">ustekinumab<a name=\"PLActiveSubstanceCodeCodeSystem-ustekinumab\"> </a></td><td>Ustekinumab (dostępny w terapii pacjentów od 6 r.ż.)</td></tr><tr><td style=\"white-space:nowrap\">ryzankizumab<a name=\"PLActiveSubstanceCodeCodeSystem-ryzankizumab\"> </a></td><td>Ryzankizumab</td></tr><tr><td style=\"white-space:nowrap\">guselkumab<a name=\"PLActiveSubstanceCodeCodeSystem-guselkumab\"> </a></td><td>Guselkumab</td></tr><tr><td style=\"white-space:nowrap\">certolizumab_pegol<a name=\"PLActiveSubstanceCodeCodeSystem-certolizumab_pegol\"> </a></td><td>Certolizumab pegol</td></tr><tr><td style=\"white-space:nowrap\">tyldrakizumab<a name=\"PLActiveSubstanceCodeCodeSystem-tyldrakizumab\"> </a></td><td>Tyldrakizumab</td></tr><tr><td style=\"white-space:nowrap\">bimekizumab<a name=\"PLActiveSubstanceCodeCodeSystem-bimekizumab\"> </a></td><td>Bimekizumab</td></tr><tr><td style=\"white-space:nowrap\">esketamina<a name=\"PLActiveSubstanceCodeCodeSystem-esketamina\"> </a></td><td>Esketamina</td></tr><tr><td style=\"white-space:nowrap\">zanubrutynib<a name=\"PLActiveSubstanceCodeCodeSystem-zanubrutynib\"> </a></td><td>Zanubrutynib</td></tr><tr><td style=\"white-space:nowrap\">daratumumab<a name=\"PLActiveSubstanceCodeCodeSystem-daratumumab\"> </a></td><td>Daratumumab</td></tr><tr><td style=\"white-space:nowrap\">entrektynib<a name=\"PLActiveSubstanceCodeCodeSystem-entrektynib\"> </a></td><td>Entrektynib</td></tr><tr><td style=\"white-space:nowrap\">rytuksymab<a name=\"PLActiveSubstanceCodeCodeSystem-rytuksymab\"> </a></td><td>Rytuksymab</td></tr><tr><td style=\"white-space:nowrap\">efgartigimod_alfa<a name=\"PLActiveSubstanceCodeCodeSystem-efgartigimod_alfa\"> </a></td><td>Efgartigimod alfa</td></tr></table></div>"
  },
  "url" : "https://ezdrowie.gov.pl/fhir/CodeSystem/PLActiveSubstanceCodeCodeSystem",
  "version" : "25.0.0",
  "name" : "PLActiveSubstanceCodeCodeSystem",
  "title" : "ActiveSubstanceCodeCodeSystem",
  "status" : "active",
  "experimental" : false,
  "date" : "2024-09-17T15:37:37+02:00",
  "publisher" : "CeZ",
  "contact" : [
    {
      "name" : "CeZ",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://ezdrowie.gov.pl"
        }
      ]
    }
  ],
  "description" : "Kody substancji czynnych",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "PL",
          "display" : "Poland"
        }
      ]
    }
  ],
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 20,
  "concept" : [
    {
      "code" : "larotrektynib",
      "display" : "Larotrektynib"
    },
    {
      "code" : "cetuksymab",
      "display" : "Cetuksymab"
    },
    {
      "code" : "panitumumab",
      "display" : "Panitumumab"
    },
    {
      "code" : "adalimumab",
      "display" : "Adalimumab (dostępny w terapii pacjentów od 4 r.ż.)"
    },
    {
      "code" : "etanercept",
      "display" : "Etanercept (dostępny w terapii pacjentów od 6 r.ż.)"
    },
    {
      "code" : "infliksymab",
      "display" : "Infliksymab"
    },
    {
      "code" : "iksekizumab",
      "display" : "Iksekizumab (dostępny w terapii pacjentów od 6 r.ż.)"
    },
    {
      "code" : "sekukinumab",
      "display" : "Sekukinumab (dostępny w terapii pacjentów od 6 r.ż.)"
    },
    {
      "code" : "ustekinumab",
      "display" : "Ustekinumab (dostępny w terapii pacjentów od 6 r.ż.)"
    },
    {
      "code" : "ryzankizumab",
      "display" : "Ryzankizumab"
    },
    {
      "code" : "guselkumab",
      "display" : "Guselkumab"
    },
    {
      "code" : "certolizumab_pegol",
      "display" : "Certolizumab pegol"
    },
    {
      "code" : "tyldrakizumab",
      "display" : "Tyldrakizumab"
    },
    {
      "code" : "bimekizumab",
      "display" : "Bimekizumab"
    },
    {
      "code" : "esketamina",
      "display" : "Esketamina"
    },
    {
      "code" : "zanubrutynib",
      "display" : "Zanubrutynib"
    },
    {
      "code" : "daratumumab",
      "display" : "Daratumumab"
    },
    {
      "code" : "entrektynib",
      "display" : "Entrektynib"
    },
    {
      "code" : "rytuksymab",
      "display" : "Rytuksymab"
    },
    {
      "code" : "efgartigimod_alfa",
      "display" : "Efgartigimod alfa"
    }
  ]
}